Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice-Reference-Cited by-同舟云学术

Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice

Published:2013-07 Issue: Volume:60 Page:80-88
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Koka Saisudha,Das Anindita,Salloum Fadi N.,Kukreja Rakesh C.

Funder

National Institutes of Health

national scientific development

American Heart Association

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference66 articles.

1. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis;Behr-Roussel;Eur. Urol.,2005

2. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of nitric oxide signaling;Das;J. Biol. Chem.,2005

3. The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5;Wallis;Nippon Yakurigaku Zasshi,1999

4. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus;Vickers;Int. J. Impot. Res.,2002

5. Sildenafil-induced cardioprotection in rabbits;Kukreja;Cardiovasc. Res.,2003

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy;International Journal of Molecular Sciences;2023-10-11

2. The effect of dapagliflozin on myocardial ischemia–reperfusion injury in diabetic rats;Canadian Journal of Physiology and Pharmacology;2023-02-01

3. Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders;Annual Review of Pharmacology and Toxicology;2023-01-20

4. Nitric Oxide-cGMP-PKG Signaling in the Cardioprotective Effects of Phosphodiesterase 5 Inhibitors;Nitric Oxide: From Research to Therapeutics;2023

5. Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine—a possible prevention strategy for COVID-19?;Molecular and Cellular Biochemistry;2022-08-29